"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Arbutus Biopharma Corp - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arbutus Biopharma Corp
Arbutus Appoints William Collier as Next President & CEO and Announces Retirement of Current President & CEO, Mark J. Murray Ph.D.
- Jun 17th, 2019 5:30 am
Arbutus to Participate at JMP Securities Life Sciences Conference
- Jun 13th, 2019 6:30 am
Is Arbutus Biopharma Corporation (NASDAQ:ABUS) Excessively Paying Its CEO?
- May 22nd, 2019 10:56 am
Arbutus to Present at Upcoming May 2019 Conferences
- May 13th, 2019 6:30 am
Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates
- May 6th, 2019 3:15 pm
Arbutus: 1Q Earnings Snapshot
- May 6th, 2019 2:45 pm
Arbutus Reports First Quarter 2019 Financial Results and Provides Corporate Update
- May 6th, 2019 2:01 pm
Arbutus to Report First Quarter 2019 Financial Results
- Apr 29th, 2019 6:30 am
Arbutus Biopharma (ABUS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
- Apr 25th, 2019 8:33 am
4 Drug/Biotech Stocks Making a Mark in RNAi Therapeutics
- Apr 11th, 2019 7:27 am
Top Ranked Momentum Stocks to Buy for April 8th
- Apr 8th, 2019 6:37 am
Arbutus Biopharma Corporation (NASDAQ:ABUS): Will The Growth Last?
- Apr 4th, 2019 1:03 pm
Arbutus Biopharma Corp (ABUS) Q4 2018 Earnings Conference Call Transcript
- Mar 7th, 2019 8:26 pm
Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
- Mar 7th, 2019 2:01 pm
Arbutus to Report Fourth Quarter and Year-End 2018 Financial Results and Provide Corporate Update
- Feb 28th, 2019 6:30 am
Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC — Research Highlights Growth, Revenue, and Consolidated Results
- Feb 4th, 2019 5:35 am
Can We See Significant Insider Ownership On The Arbutus Biopharma Corporation (NASDAQ:ABUS) Share Register?
- Jan 22nd, 2019 8:13 am
Do Hedge Funds Love Arbutus Biopharma Corp (ABUS)?
- Dec 23rd, 2018 1:40 am
New Research Coverage Highlights Nokia, SecureWorks, National Western Life Group, Brookfield Asset Management, FormFactor, and Arbutus Biopharma — Consolidated Revenues, Company Growth, and Expectations for 2018
- Dec 11th, 2018 5:55 am
Is PennyMac Financial Services Inc (PFSI) A Good Stock To Buy?
- Dec 8th, 2018 8:03 pm
Frequently Asked Questions
Terms and Conditions
Copyright © 2019 VentureLine
Website developed by Digital Solutions